1Kurz JF. Secretolysis through gelomyrtol[J ]. Z Allgemeinmed,1970, Nov 46 : 1623-1627. 被引量：1
2Behrbohm H, Kaschke O, Sydow K. Effect of the phytogenic secretolytic drug Gelomytrol forte on mucociliary clearance of the maxillary sinus[ J ]. Laryngorhinootologie, 1995, 74: 793-797. 被引量：1
3Beuscher N, Kietzmann M, Bien E, et al. Interference of Myrtol Standardized with Inflammatory and Allergic Mediators[J ].Arzneimittelforschung. 1998, Oct 48:985-989. 被引量：1
4Grassmann J, Hippeli S, Dornisch K, et al. Antioxidant properties of essential oils. Possible explanations for their anti-inflammatory effects[J]. Arneimittelforsc-hung. 2000, Feb 50: 135-139. 被引量：1
5Straehler-Pohl HJ, Burmeister G. Use of Gelomyrtol forte in sinusitides A course study[J]. ZFA (Stuttgart). 1978, Apr 54:611-615. 被引量：1
6Federspil P, Wulkow R, Zimmermann T. Effects of standardized Myrtol in therapy of acute sinusitis-results of a double-blind,randomized multicenter study compared with placebo[J]. Laryngorhinootologie. 1997, 76:23-27. 被引量：1
7Matthys H, De Mey C, Carls C, et al. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. Cefuroxime and ambroxol[ J ]. Arzneimittelforschung,2000, 50:700-711. 被引量：1
8Meister R, Witting T, Beuscher N, et al. Efficacy and Tolerability of Myrtol Standardized in Long-term Treatment of Chronic Bronchitis. A double-blind, placebo-controlled study. Study Group Investigators[J]. Arzneimttelforsc-hung, 1999, 49:351-358. 被引量：1
9Ulmer WT, Scha D. Chronic obstructive bronchitis. Effect of Gelomrtol forte in a placebo-controlled double-blind study[J ].Fortschr Med. 1991, 109:547-550. 被引量：1
10Sengespeik HC, Zimmermann T, Peiske C, et al. Myrtol Standardized in the Treatment of Acute and Chronic Respiratory Infections in Children/A multicenter postmarketing surveillance study[J]. Arzneimittelforsc-hung, 1998, 48:990-994. 被引量：1
